74 related articles for article (PubMed ID: 22962269)
1. Iodide transporter NIS regulates cancer cell motility and invasiveness by interacting with the Rho guanine nucleotide exchange factor LARG.
Lacoste C; Hervé J; Bou Nader M; Dos Santos A; Moniaux N; Valogne Y; Montjean R; Dorseuil O; Samuel D; Cassio D; Portulano C; Carrasco N; Bréchot C; Faivre J
Cancer Res; 2012 Nov; 72(21):5505-15. PubMed ID: 22962269
[TBL] [Abstract][Full Text] [Related]
2. The BRAFV600E oncogene induces transforming growth factor beta secretion leading to sodium iodide symporter repression and increased malignancy in thyroid cancer.
Riesco-Eizaguirre G; Rodríguez I; De la Vieja A; Costamagna E; Carrasco N; Nistal M; Santisteban P
Cancer Res; 2009 Nov; 69(21):8317-25. PubMed ID: 19861538
[TBL] [Abstract][Full Text] [Related]
3. Positive feedback between Dia1, LARG, and RhoA regulates cell morphology and invasion.
Kitzing TM; Sahadevan AS; Brandt DT; Knieling H; Hannemann S; Fackler OT; Grosshans J; Grosse R
Genes Dev; 2007 Jun; 21(12):1478-83. PubMed ID: 17575049
[TBL] [Abstract][Full Text] [Related]
4. A Nonpump Function of Sodium Iodide Symporter in Thyroid Cancer via Cross-talk with PTEN Signaling.
Feng F; Yehia L; Ni Y; Chang YS; Jhiang SM; Eng C
Cancer Res; 2018 Nov; 78(21):6121-6133. PubMed ID: 30217930
[TBL] [Abstract][Full Text] [Related]
5. The role of the guanine nucleotide exchange factor Tiam1 in cellular migration, invasion, adhesion and tumor progression.
Minard ME; Kim LS; Price JE; Gallick GE
Breast Cancer Res Treat; 2004 Mar; 84(1):21-32. PubMed ID: 14999151
[TBL] [Abstract][Full Text] [Related]
6. Direct interaction of insulin-like growth factor-1 receptor with leukemia-associated RhoGEF.
Taya S; Inagaki N; Sengiku H; Makino H; Iwamatsu A; Urakawa I; Nagao K; Kataoka S; Kaibuchi K
J Cell Biol; 2001 Nov; 155(5):809-20. PubMed ID: 11724822
[TBL] [Abstract][Full Text] [Related]
7. The RacGEF Tiam1 inhibits migration and invasion of metastatic melanoma via a novel adhesive mechanism.
Uhlenbrock K; Eberth A; Herbrand U; Daryab N; Stege P; Meier F; Friedl P; Collard JG; Ahmadian MR
J Cell Sci; 2004 Sep; 117(Pt 20):4863-71. PubMed ID: 15340013
[TBL] [Abstract][Full Text] [Related]
8. A specific isoform of glial cell line-derived neurotrophic factor family receptor alpha 1 regulates RhoA expression and glioma cell migration.
Wan G; Too HP
J Neurochem; 2010 Nov; 115(3):759-70. PubMed ID: 20807316
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II up-regulates the leukemia-associated Rho guanine nucleotide exchange factor (RhoGEF), a regulator of G protein signaling domain-containing RhoGEF, in vascular smooth muscle cells.
Ying Z; Jin L; Palmer T; Webb RC
Mol Pharmacol; 2006 Mar; 69(3):932-40. PubMed ID: 16354763
[TBL] [Abstract][Full Text] [Related]
10. Neuropeptide-stimulated cell migration in prostate cancer cells is mediated by RhoA kinase signaling and inhibited by neutral endopeptidase.
Zheng R; Iwase A; Shen R; Goodman OB; Sugimoto N; Takuwa Y; Lerner DJ; Nanus DM
Oncogene; 2006 Sep; 25(44):5942-52. PubMed ID: 16652149
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of dedicator of cytokinesis I (Dock180) in ovarian cancer correlated with aggressive phenotype and poor patient survival.
Zhao F; Siu MK; Jiang L; Tam KF; Ngan HY; Le XF; Wong OG; Wong ES; Chan HY; Cheung AN
Histopathology; 2011 Dec; 59(6):1163-72. PubMed ID: 22175896
[TBL] [Abstract][Full Text] [Related]
12. LARG links histamine-H1-receptor-activated Gq to Rho-GTPase-dependent signaling pathways.
Pfreimer M; Vatter P; Langer T; Wieland T; Gierschik P; Moepps B
Cell Signal; 2012 Mar; 24(3):652-63. PubMed ID: 22100544
[TBL] [Abstract][Full Text] [Related]
13. Mitogen-activated protein kinase signaling enhances sodium iodide symporter function and efficacy of radioiodide therapy in nonthyroidal cancer cells.
Jung KH; Paik JY; Ko BH; Lee KH
J Nucl Med; 2008 Dec; 49(12):1966-72. PubMed ID: 18997042
[TBL] [Abstract][Full Text] [Related]
14. Maximizing tumor cell invasion.
Ongusaha PP; Lee SW
Pigment Cell Melanoma Res; 2009 Apr; 22(2):148-9. PubMed ID: 19175753
[No Abstract] [Full Text] [Related]
15. Rho-regulatory proteins in breast cancer cell motility and invasion.
Lin M; van Golen KL
Breast Cancer Res Treat; 2004 Mar; 84(1):49-60. PubMed ID: 14999154
[TBL] [Abstract][Full Text] [Related]
16. Histidine residue at position 226 is critical for iodide uptake activity of human sodium/iodide symporter.
Wu SL; Ho TY; Liang JA; Hsiang CY
J Endocrinol; 2008 Nov; 199(2):213-9. PubMed ID: 18708479
[TBL] [Abstract][Full Text] [Related]
17. PTEN inhibits PREX2-catalyzed activation of RAC1 to restrain tumor cell invasion.
Mense SM; Barrows D; Hodakoski C; Steinbach N; Schoenfeld D; Su W; Hopkins BD; Su T; Fine B; Hibshoosh H; Parsons R
Sci Signal; 2015 Mar; 8(370):ra32. PubMed ID: 25829446
[TBL] [Abstract][Full Text] [Related]
18. A role for phospholipase C-gamma-mediated signaling in tumor cell invasion.
Kassis J; Moellinger J; Lo H; Greenberg NM; Kim HG; Wells A
Clin Cancer Res; 1999 Aug; 5(8):2251-60. PubMed ID: 10473113
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of rho-associated kinase signaling prevents breast cancer metastasis to human bone.
Liu S; Goldstein RH; Scepansky EM; Rosenblatt M
Cancer Res; 2009 Nov; 69(22):8742-51. PubMed ID: 19887617
[TBL] [Abstract][Full Text] [Related]
20. Stimulation of retinoic acid-induced functional sodium iodide symporter (NIS) expression and cytotoxicity of ¹³¹I by carbamazepine in breast cancer cells.
Willhauck MJ; O Kane DJ; Wunderlich N; Göke B; Spitzweg C
Breast Cancer Res Treat; 2011 Jan; 125(2):377-86. PubMed ID: 20300827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
